title: Regression of indolent B-cell lymphoma after Lamivudine prophylaxis of hepatitis B virus infection.
authors.affiliation: University of Pavia Medical School, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy.
authors.forename: Luca
authors.initials: L
authors.lastname: Arcaini
authors.forename: Michele
authors.initials: M
authors.lastname: Merli
authors.forename: Sara
authors.initials: S
authors.lastname: Rattotti
authors.forename: Raffaele
authors.initials: R
authors.lastname: Bruno
authors.forename: Alessandro
authors.initials: A
authors.lastname: Vercelli
authors.forename: Marco
authors.initials: M
authors.lastname: Lucioni
authors.forename: Roberta
authors.initials: R
authors.lastname: Riboni
authors.forename: Marco
authors.initials: M
authors.lastname: Paulli
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D058070:Asymptomatic Diseases; D001853:Bone Marrow / Q000473:pathology; D002353:Carrier State / Q000188:drug therapy*; D002472:Cell Transformation, Viral; D018450:Disease Progression; D005260:Female; D019254:Genes, bcl-2; D006509:Hepatitis B / Q000150:complications / Q000188:drug therapy*; D006515:Hepatitis B virus / Q000472:pathogenicity; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D016393:Lymphoma, B-Cell / Q000150:complications* / Q000235:genetics / Q000821:virology; D008224:Lymphoma, Follicular / Q000150:complications* / Q000235:genetics / Q000821:virology; D008875:Middle Aged; D018365:Neoplasm, Residual; D012074:Remission Induction; D013160:Splenic Neoplasms / Q000150:complications* / Q000235:genetics / Q000821:virology
chemical_list: D000998:Antiviral Agents; D019259:Lamivudine